Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Bra/Brb alloantigen system on human platelets.

V Kiefel1, S Santoso, B Katzmann

  • 1Institute for Clinical Immunology, Justus-Liebig-University, Giessen, Federal Republic of Germany.

Blood
|June 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alloimmunization against platelet-specific antigen Dik on glycoprotein IIb in a case of fetal-neonatal alloimmune thrombocytopenia.

Transfusion·2025
Same author

Psychotherapeutic modalities for phantom limb pain: a scoping review.

East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan·2025
Same author

Assessment of HNA alloimmunisation risk in Northeastern Thais, Burmese and Karen.

Transfusion medicine (Oxford, England)·2017
Same author

Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness.

Transfusion medicine (Oxford, England)·2017
Same author

The prevalence of leucocyte alloantibodies in blood donors from South China.

Transfusion medicine (Oxford, England)·2016
Same author

Two cases of platelet transfusion refractoriness and one case of possible FNAIT caused by antibodies against CD36 in China.

Transfusion medicine (Oxford, England)·2014
Same journal

Decentralized Clinical Trials in Hematology: the Promise and the Peril.

Blood·2026
Same journal

How I Treat Chemotherapy-Induced Thrombocytopenia with Thrombopoietin Receptor Agonists.

Blood·2026
Same journal

The Chaos of Choice in Large B-cell Lymphoma: A Call to Harmonize First-line Trial Design.

Blood·2026
Same journal

Precision Transfusion Medicine in the Omics Era.

Blood·2026
Same journal

Fibrocytes drive JAK2V617F-mutated myelofibrosis: pitavastatin reverses marrow fibrosis and anemia.

Blood·2026
Same journal

Identifying steroid-refractory aGVHD before it happens.

Blood·2026
See all related articles

Researchers discovered a new platelet antigen, Brb, an allele of Bra, crucial for understanding neonatal alloimmune thrombocytopenia (NAIT) and polytransfused patients. This finding reveals the first polymorphism on the glycoprotein Ia/IIa complex.

Area of Science:

  • Immunology
  • Hematology
  • Genetics

Background:

  • Neonatal alloimmune thrombocytopenia (NAIT) is a condition where maternal antibodies target fetal platelet antigens.
  • The Bra antigen, located on the glycoprotein (GP) Ia/IIa complex, is implicated in NAIT.
  • Existing detection methods include the monoclonal antibodies for antigen immobilization (MAIPA) assay and radioimmunoprecipitation (RIP).

Purpose of the Study:

  • To identify and characterize new platelet-specific alloantigens.
  • To investigate the genetic inheritance and frequency of novel platelet antigens.
  • To understand the role of these antigens in transfusion reactions and NAIT.

Main Methods:

  • Analysis of sera from patients with NAIT and polytransfused individuals.

Related Experiment Videos

  • Utilized glycoprotein-specific immunoassays, including MAIPA and RIP.
  • Conducted family studies to determine inheritance patterns.

    • Main Results:

    • Identified a novel antibody recognizing Brb, an allele of the previously known Bra antigen.
    • Brb and Bra are inherited as autosomal codominant traits.
    • The gene frequency of the Brb allele is 0.888, with approximately 2,000 binding sites on homozygous and 1,000 on heterozygous platelets.
    • This represents the first observed polymorphism on the GP Ia/IIa complex.

    Conclusions:

    • The discovery of the Brb allele provides new insights into platelet antigen polymorphism.
    • These findings are significant for diagnosing and managing NAIT and complications in polytransfused patients.
    • Further research into GP Ia/IIa complex polymorphism may improve transfusion compatibility and outcomes.